- Home
- SNES vs NAII Comparison
SNES vs NAII Comparison
Compare SNES & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNES
- NAII
- Stock Information
- Founded
- SNES 2004
- NAII 1980
- Country
- SNES United States
- NAII United States
- Employees
- SNES N/A
- NAII N/A
- Industry
- SNES Agricultural Chemicals
- NAII Medicinal Chemicals and Botanical Products
- Sector
- SNES Industrials
- NAII Health Care
- Exchange
- SNES Nasdaq
- NAII Nasdaq
- Market Cap
- SNES 21.0M
- NAII 21.2M
- IPO Year
- SNES 2016
- NAII 1987
- Fundamental
- Price
- SNES $5.02
- NAII $3.44
- Analyst Decision
- SNES Strong Buy
- NAII
- Analyst Count
- SNES 1
- NAII 0
- Target Price
- SNES $10.00
- NAII N/A
- AVG Volume (30 Days)
- SNES 79.9K
- NAII 5.3K
- Earning Date
- SNES 08-07-2025
- NAII 09-26-2025
- Dividend Yield
- SNES N/A
- NAII N/A
- EPS Growth
- SNES N/A
- NAII N/A
- EPS
- SNES N/A
- NAII N/A
- Revenue
- SNES $2,093,000.00
- NAII $125,483,000.00
- Revenue This Year
- SNES $130.53
- NAII N/A
- Revenue Next Year
- SNES $22.87
- NAII N/A
- P/E Ratio
- SNES N/A
- NAII N/A
- Revenue Growth
- SNES 36.89
- NAII 4.39
- 52 Week Low
- SNES $1.30
- NAII $2.57
- 52 Week High
- SNES $6.24
- NAII $6.88
- Technical
- Relative Strength Index (RSI)
- SNES 54.78
- NAII 39.13
- Support Level
- SNES $4.76
- NAII $3.58
- Resistance Level
- SNES $5.15
- NAII $3.93
- Average True Range (ATR)
- SNES 0.24
- NAII 0.14
- MACD
- SNES 0.03
- NAII -0.05
- Stochastic Oscillator
- SNES 82.67
- NAII 6.35
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.